Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Male hair loss is mainly due to thinner hair, not less hair.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Hair aging is inevitable, but using the right hair care products can help maintain hair health.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.